Teva Pharmaceutical Industries Ltd (TEVA) Earning Prediction
Teva Pharmaceutical Industries Ltd (TEVA) is set to release its earnings performance on 01/28 05:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 4.00B and an earnings per share (EPS) of 0.63 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
TEVA Transcript
The earnings call presents a generally positive outlook with strong growth expectations for key products like AUSTEDO and UZEDY, a robust pipeline, and effective cost management strategies. However, management's cautious approach in providing specific guidance for certain products and data may limit the upside potential. The overall sentiment is positive, supported by optimistic guidance and strategic initiatives, likely resulting in a stock price increase of 2% to 8% over the next two weeks.
TEVA Report
Frequently Asked Questions
What is the Teva Pharmaceutical Industries Ltd Earnings Release Date and Time?
Teva Pharmaceutical Industries Ltd (TEVA) is scheduled to release its earnings report onJan 28, 2026, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Teva Pharmaceutical Industries Ltd Revenue and EPS?
Analysts' consensus predicts 4.00B in revenue and an EPS of 1.00 for Teva Pharmaceutical Industries Ltd's .
What Does Intellectia's AI Predict for Teva Pharmaceutical Industries Ltd Earnings?
Intellectia's exclusive AI algorithms forecast a forTeva Pharmaceutical Industries Ltd's earnings, with a prediction date of Jan 28, 2026. Teva Pharmaceutical Industries Ltd
How Can I Use This Earnings Prediction to Trade TEVA Stock?
Leverage Intellectia's AI forecast to position trades ahead of theJan 28, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Teva Pharmaceutical Industries Ltd ?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
